Eli Lilly’s GLP?1 blockbuster Mounjaro is transforming obesity and diabetes treatment in the US — ...
Eli Lilly’s Mounjaro has rapidly become the defining drug ...
Skye Bioscience präsentiert vollständige Phase-2a-Daten ...
Viking Therapeutics US92686J1060
GNW-News: European Biopharma Obesity Innovation Forum startet ...
Bellevue Asset Management lanciert Obesity Solutions Fonds